{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:09:22Z","timestamp":1788948562697,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangxi Natural Science Foundation","award":["No.2020GXNSFAA159127"],"award-info":[{"award-number":["No.2020GXNSFAA159127"]}]},{"name":"Medical Excellence Award\u201d Funded by the Creative Research Development Grant from the First Affiliated Hospital of Guangxi Medical University","award":["No. 2021006"],"award-info":[{"award-number":["No. 2021006"]}]},{"name":"Guangxi Medical and Health Appropriate Technology Development and Application Project","award":["No. S2021100"],"award-info":[{"award-number":["No. S2021100"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81802874"],"award-info":[{"award-number":["81802874"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) is one of the most common cancer worldwide. In this study, we performed a two-stage exome-chip association analysis and found that the aldo-keto reductase family7 member A3 (AKR7A3) rs1738023 may be a potential susceptibility locus for HCC in females. We aimed to explore its role and mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The association between genotype and phenotype was analyzed through GWAS method. The expression of AKR7A3 in cancer tissue and blood analysis by qRT-PCR. The relationship of AKR7A3 and aflatoxin B1 (AFB1) was also analyzed. The effect of AKR7A3 on the biological behavior of HCC cell line was investigated on proliferation and invasion. The potential mechanism was analyzed by transcriptome analysis and western blot.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Through genome-wide association analysis (GWAS), AKR7A3 (rs1738023), KIF2C (rs4342887), and CYP3A5 (rs6977165 and rs4646450) were found to be associated with susceptibility to hepatocellular carcinoma (HCC) in women. Further expression quantitative trait loci (eQTL) analysis showed that only AKR7A3 (rs1738023) was significantly associated with gene expression. The expression of AKR7A3 was significantly lower in HCC than adjacent non-tumorous tissues (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The genotype of rs1738023 was significantly associated with AKR7A3 expression (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0085). Rs1738023[C] genotype had a low AKR7A3 expression level and limited detoxification ability of AFB1. Literature data showed that AKR7A3 is involved in the metabolism of aflatoxin B1 (AFB1). Functional experimental results showed that overexpression of AKR7A3 in the normal liver cell line HL-7702 could significantly reduce AFB1-induced ROS levels and DNA adduct formation, suggesting that it plays a protective role in AFB1 metabolic detoxification. Cell function test showed that overexpression of AKR7A3 inhibit the proliferation, migration and invasion of HCC cells, and block the cell cycle. Transcriptome sequencing and KEGG pathway enrichment analysis revealed that overexpression of AKR7A3 affected the PI3K signaling pathway and led to downregulation of HIF1A and its downstream VEGFA protein expression. The validation results were confirmed in HCC cell lines Huh-7 and SUN-387.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overexpression of AKR7A3 contributes to inhibition of HCC progression and reduction of aflatoxin toxicity. AKR7A3 may serve as a potential prognostic and therapeutic target for HCC patients, although further validation is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12672-026-05757-9","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:15:56Z","timestamp":1787595356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AKR7A3 rs1738023 association with susceptibility to female hepatocellular carcinoma and its role in AFB1 metabolism and tumor"],"prefix":"10.1007","volume":"17","author":[{"given":"Jiakao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangye","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"issue":"1","key":"5757_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023 . CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5757_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries . CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5757_CR3","first-page":"e70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics. CA Cancer J Clin. 2026;76(1):e70043.","journal-title":"CA Cancer J Clin"},{"issue":"10360","key":"5757_CR4","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma . Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"issue":"2","key":"5757_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and Management of Hepatocellular Carcinoma . Gastroenterology. 2019;156(2):477\u201391. e1.","journal-title":"Gastroenterology"},{"issue":"12","key":"5757_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"HB El-Serag","year":"2011","unstructured":"El-Serag HB. Hepatocellular carcinoma . N Engl J Med. 2011;365(12):1118\u201327.","journal-title":"N Engl J Med"},{"issue":"8","key":"5757_CR7","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1111\/cas.15798","volume":"114","author":"L Hua","year":"2023","unstructured":"Hua L, Song Y, Min J, et al. AKR7A3 modulates the metastasis of pancreatic ductal adenocarcinoma through regulating PHGDH-suppressed autophagy. Cancer Sci. 2023;114(8):3101\u201313.","journal-title":"Cancer Sci"},{"issue":"1","key":"5757_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","volume":"27","author":"P Ganesan","year":"2023","unstructured":"Ganesan P, Kulik LM. Hepatocellular Carcinoma: New Developments. Clin Liver Dis. 2023;27(1):85\u2013102.","journal-title":"Clin Liver Dis"},{"issue":"Suppl0","key":"5757_CR9","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","volume":"47","author":"S Mittal","year":"2013","unstructured":"Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population . J Clin Gastroenterol. 2013;47(Suppl0):S2\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"5757_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0165-1110(96)90005-6","volume":"366","author":"HM Shen","year":"1996","unstructured":"Shen HM, Ong CN. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis . Mutat Res. 1996;366(1):23\u201344.","journal-title":"Mutat Res"},{"issue":"2","key":"5757_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1349-7006.2006.00380.x","volume":"98","author":"T Peng","year":"2007","unstructured":"Peng T, Li LQ, Peng MH, et al. Is correction for protein concentration appropriate for protein adduct dosimetry? Hypothesis and clues from an aflatoxin B1-exposed population . Cancer Sci. 2007;98(2):140\u20136.","journal-title":"Cancer Sci"},{"issue":"21","key":"5757_CR12","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/jnci\/93.21.1644","volume":"93","author":"MW Yu","year":"2001","unstructured":"Yu MW, Yang YC, Yang SY, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men . J Natl Cancer Inst. 2001;93(21):1644\u201351.","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"5757_CR13","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/jnci\/92.24.2023","volume":"92","author":"MW Yu","year":"2000","unstructured":"Yu MW, Cheng SW, Lin MW, et al. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma . J Natl Cancer Inst. 2000;92(24):2023\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5757_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajhg.2011.11.029","volume":"90","author":"PM Visscher","year":"2012","unstructured":"Visscher PM, Brown MA, Mccarthy MI, et al. Five years of GWAS discovery . Am J Hum Genet. 2012;90(1):7\u201324.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"5757_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ng.638","volume":"42","author":"H Zhang","year":"2010","unstructured":"Zhang H, Zhai Y, Hu Z, et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers . Nat Genet. 2010;42(9):755\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"5757_CR16","first-page":"895","volume":"42","author":"Q Han","year":"2019","unstructured":"Han Q, Wang X, Liao X, et al. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus\u2013related hepatocellular carcinoma . Oncol Rep. 2019;42(3):895\u2013910.","journal-title":"Oncol Rep"},{"key":"5757_CR17","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.2147\/OTT.S140221","volume":"10","author":"X Liao","year":"2017","unstructured":"Liao X, Huang R, Liu X, et al. Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma . Onco Targets Ther. 2017;10:3719\u201332.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"5757_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.21037\/atm-21-6240","volume":"10","author":"S Mo","year":"2022","unstructured":"Mo S, Fang D, Zhao S, et al. Down regulated oncogene KIF2C inhibits growth, invasion, and metastasis of hepatocellular carcinoma through the Ras\/MAPK signaling pathway and epithelial-to-mesenchymal transition . Ann Transl Med. 2022;10(3):151.","journal-title":"Ann Transl Med"},{"issue":"4","key":"5757_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method . Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"key":"5757_CR20","first-page":"199","volume":"99","author":"RM Santella","year":"1993","unstructured":"Santella RM, Zhang YJ, Chen CJ, et al. Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue . Environ Health Perspect. 1993;99:199\u2013202.","journal-title":"Environ Health Perspect"},{"issue":"7","key":"5757_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1143::AID-CNCR7>3.0.CO;2-Z","volume":"86","author":"CM Lee","year":"1999","unstructured":"Lee CM, Lu SN, Changchien CS, et al. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection . Cancer. 1999;86(7):1143\u201350.","journal-title":"Cancer"},{"issue":"1","key":"5757_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/1097-0142(19950101)75:1<18::AID-CNCR2820750105>3.0.CO;2-#","volume":"75","author":"IO Ng","year":"1995","unstructured":"Ng IO, Ng MM, Lai EC, et al. Better survival in female patients with hepatocellular carcinoma. Possible causes from a pathologic approach . Cancer. 1995;75(1):18\u201322.","journal-title":"Cancer"},{"key":"5757_CR23","unstructured":"He J, Chen WQ, Shen HB, et al. China guideline for liver cancer screening (2022, Beijing)[J]. J Clin Hepatol, 2022, 38(8): 1739-1758. 2022.08.007."},{"issue":"6","key":"5757_CR24","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.annonc.2022.03.009","volume":"33","author":"A Vogel","year":"2022","unstructured":"Vogel A, Cervantes A, Chau I, et al. Corrigendum to Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: [Annals of Oncology 29 suppl. 4 (2018) v238-iv255] . Ann Oncol. 2022;33(6):666.","journal-title":"Ann Oncol"},{"issue":"7","key":"5757_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11864-023-01098-9","volume":"24","author":"B Alawyia","year":"2023","unstructured":"Alawyia B, Constantinou C. Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects . Curr Treat Options Oncol. 2023;24(7):711\u201324.","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"5757_CR26","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1021\/tx7004458","volume":"21","author":"S Bodreddigari","year":"2008","unstructured":"Bodreddigari S, Jones LK, Egner PA, et al. Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3 . Chem Res Toxicol. 2008;21(5):1134\u201342.","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"5757_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.1365-2443.2000.00310.x","volume":"5","author":"M Nishizawa","year":"2000","unstructured":"Nishizawa M, Nakajima T, Yasuda K, et al. Close kinship of human 20alpha-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes . Genes Cells. 2000;5(2):111\u201325.","journal-title":"Genes Cells"},{"issue":"5","key":"5757_CR28","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1021\/tx3000945","volume":"25","author":"BA Merrick","year":"2012","unstructured":"Merrick BA, Auerbach SS, Stockton PS, et al. Testing an aflatoxin B1 gene signature in rat archival tissues . Chem Res Toxicol. 2012;25(5):1132\u201344.","journal-title":"Chem Res Toxicol"},{"key":"5757_CR29","doi-asserted-by":"crossref","unstructured":"Dewa Y, Nishimura J, Muguruma M et al. beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats . Toxicology, 2008, 244(2\u20133): 179\u2009\u2013\u200989.","DOI":"10.1016\/j.tox.2007.11.010"},{"issue":"9","key":"5757_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00204-007-0190-9","volume":"81","author":"Y Dewa","year":"2007","unstructured":"Dewa Y, Nishimura J, Muguruma M, et al. Gene expression analyses of the liver in rats treated with oxfendazole . Arch Toxicol. 2007;81(9):647\u201354.","journal-title":"Arch Toxicol"},{"key":"5757_CR31","doi-asserted-by":"publisher","first-page":"103639","DOI":"10.1016\/j.redox.2025.103639","volume":"83","author":"X Zhang","year":"2025","unstructured":"Zhang X, Gschwind J, Erben V, et al. Endogenous acrolein accumulation in akr7a3 mutants causes microvascular dysfunction due to increased arachidonic acid metabolism. Redox Biol. 2025;83:103639.","journal-title":"Redox Biol"},{"issue":"4","key":"5757_CR32","first-page":"3547","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Yao L, Yang J, et al. PI3K\/Akt and HIF\u20131 signaling pathway in hypoxia\u2013ischemia (Review) . Mol Med Rep. 2018;18(4):3547\u201354.","journal-title":"Mol Med Rep"},{"issue":"28","key":"5757_CR33","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1097\/MD.0000000000000255","volume":"93","author":"V Hlavac","year":"2014","unstructured":"Hlavac V, Brynychova V, Vaclavikova R, et al. The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients . Med (Baltim). 2014;93(28):e255.","journal-title":"Med (Baltim)"},{"key":"5757_CR34","doi-asserted-by":"publisher","first-page":"888672","DOI":"10.3389\/fgene.2022.888672","volume":"13","author":"K Peng","year":"2022","unstructured":"Peng K, Ren X, Ren Q. NcRNA-mediated upregulation of CAMK2N1 is associated with poor prognosis and tumor immune infiltration of gastric cancer . Front Genet. 2022;13:888672.","journal-title":"Front Genet"},{"issue":"2","key":"5757_CR35","doi-asserted-by":"publisher","first-page":"a002915","DOI":"10.1101\/cshperspect.a002915","volume":"2","author":"J Heuberger","year":"2010","unstructured":"Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling . Cold Spring Harb Perspect Biol. 2010;2(2):a002915.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5757_CR36","doi-asserted-by":"crossref","unstructured":"Ignatavicius P, Dauksa A, Zilinskas J et al. DNA Methylation of HOXA11 Gene as Prognostic Molecular Marker in Human Gastric Adenocarcinoma . Diagnostics (Basel), 2022, 12(7).","DOI":"10.3390\/diagnostics12071686"},{"issue":"4","key":"5757_CR37","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s10620-018-4943-5","volume":"63","author":"JE Torres-Mena","year":"2018","unstructured":"Torres-Mena JE, Salazar-Villegas KN, Sanchez-Rodriguez R, et al. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC . Dig Dis Sci. 2018;63(4):934\u201344.","journal-title":"Dig Dis Sci"},{"issue":"48","key":"5757_CR38","doi-asserted-by":"publisher","first-page":"83469","DOI":"10.18632\/oncotarget.12726","volume":"8","author":"RKK Chow","year":"2017","unstructured":"Chow RKK, Tsz-Kwan Sin S, Liu M, et al. AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-kappaB signaling pathways . Oncotarget. 2017;8(48):83469\u201379.","journal-title":"Oncotarget"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05757-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05757-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05757-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:41:02Z","timestamp":1788946862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05757-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5757"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05757-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (2015(KY-E-025)). A written informed consent was obtained from all the patients for their data to be used for research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not contain any personally identifiable information or images, and individual consent for publication is not required. Hence, it is not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1318"}}